[Federal Register Volume 75, Number 209 (Friday, October 29, 2010)]
[Notices]
[Page 66766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-27317]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


NIAID Blue Ribbon Panel Meeting on Adjuvant Discovery and 
Development

    Notice is hereby given that the National Institute of Allergy and 
Infectious Diseases (NIAID), a component of the National Institutes of 
Health (NIH) of the Department of Health and Human Services (DHHS), 
will convene a Blue Ribbon Panel to provide expertise in developing a 
strategic plan and research agenda for the discovery, development and 
clinical evaluation of adjuvants for use with preventive vaccines. 
NIAID has developed a draft Strategic Plan and Research Agenda for 
Adjuvant Discovery and Development, which summarizes the current status 
of research in the field of preventive vaccine adjuvants, identifies 
gaps in knowledge and capabilities, and defines NIAID's goals for the 
continued discovery, development and application of adjuvants for human 
vaccines that protect against infectious disease. The Panel will review 
the draft Strategic Plan and Research Agenda and recommend ways the 
NIAID can enhance its adjuvant research programs.

DATES: November 17-18, 2010.

ADDRESSES: The meeting location is: Rockville--Hilton Hotel (Roosevelt 
Room), 1750 Rockville Pike, Rockville, MD 20850.

FOR FURTHER INFORMATION CONTACT: Ms. Grace Tollini-Farrell, 301-496-
7551.

    Dated: October 21, 2010.
Daniel Rotrosen,
Director, Division of Allergy, Immunology and Transplantation, NIAID, 
National Institutes of Health.
[FR Doc. 2010-27317 Filed 10-28-10; 8:45 am]
BILLING CODE 4140-01-P